In this episode of the Huberman Lab podcast, Dr. Mary Claire Haver sheds light on the intricacies of menopause and perimenopause, offering a more comprehensive understanding of these transitional periods beyond the conventional definitions. She delves into the symptoms and effects associated with fluctuating hormone levels during perimenopause and the long-term health implications that arise post-menopause.
Haver provides insights on lifestyle and nutritional approaches, emphasizing the importance of an anti-inflammatory, protein-rich diet and regular resistance training. Additionally, she explores hormone replacement therapy (HRT) as a crucial component in managing menopausal symptoms and mitigating long-term health risks, while also discussing other treatments and supplements with varying levels of evidence.
Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Dr. Mary Claire Haver criticizes the typical definition of menopause as merely the cessation of periods for a year, suggesting "hypogonadism for females" better captures the decline in ovarian function and sex hormone production. Perimenopause is the 7-10 year transition marked by irregular cycles and fluctuating hormone levels, dubbed the "zone of chaos." Its onset varies from 45-55 years old due to genetic and lifestyle factors like ovulation suppression.
During perimenopause, fluctuations in estrogen and neurotransmitters like serotonin increase risks of anxiety, depression, cognitive issues, and one in five women quitting jobs, according to Haver. Menopause leads to a shift from muscle to visceral fat, raising cardiometabolic disease risk independent of diet and exercise changes.
Haver recommends an anti-inflammatory, high-protein diet with 80-120g daily spread evenly. Resistance training 3-4 times weekly and weighted vests combat muscle and bone loss.
Haver highlights HRT, especially estrogen therapy, as crucial for managing menopause symptoms and reducing long-term health risks. Starting HRT between 50-59 provides maximal cardiovascular and cognitive protection. However, it's contraindicated in hormone-sensitive cancers. Local/vaginal estrogen offers targeted benefits.
Evidence is mixed on supplements like collagen, creatine, vitamin D for bone/muscle health. Lifestyle therapies like acupuncture, sleep hygiene may aid symptom management. Medications exist for libido issues.
1-Page Summary
Understanding the stages of a woman's reproductive life is vital, including the transitional phase known as perimenopause and the cessation of menstrual periods termed menopause. Dr. Mary Claire Haver provides clarity on these two stages, emphasizing the role of hormonal changes and advocating for a broader definition of menopause that goes beyond merely the absence of periods.
Menopause is commonly defined as the cessation of menstrual periods for one year, but Dr. Haver criticizes this definition for failing to include scenarios such as hysterectomy, IUD use, ablation, PCOS, or other causes where women do not have menstrual periods. She suggests that the term "hypogonadism for females" could be more appropriate, as it encapsulates the complex endocrine interactions that occur with the decline of ovarian function, also known as ovarian senescence. This decline leads to a depletion of egg supply and a significant decrease in the production of sex hormones such as estradiol, progesterone, and testosterone from the ovaries.
Dr. Haver highlights that menopause signifies more than just the end of periods; it represents the conclusion of ovarian function and a downward trend in estradiol levels, resulting in women post-menopause having lower estradiol levels than those who are premenopausal. She underscores the need for more research into why ovarian cells become resistant to Follicle-Stimulating Hormone (FSH) during perimenopause and what happens at the receptor level, noting the disparity in research compared to other reproductive topics.
Perimenopause is characterized as the transitional phase lasting 7-10 years before the cessation of menstruation, during which the regular monthly hormone cycle becomes erratic, leading to unpredictable menstrual cycles. During this period, the decrease in the egg supply reduces the effectiveness of the brain's si ...
Defining and understanding menopause and perimenopause
Mary Claire Haver outlines the significant mental and physical health changes women undergo during perimenopause and menopause, emphasizing the importance of hormone therapy, the impact on sexual function, and the rise of cardiometabolic disease risk.
The "zone of chaos" of hormonal fluctuations during perimenopause significantly increases the risk of mental health disorders, particularly depression. Haver points out that at least a 40% increase in mental health disorders can occur during this stage, with usage of SSRIs doubling across the transition. Anxiety symptoms heighten, executive functioning suffers, leading to ADD-type symptoms, and cognitive issues like "brain fog" become common. This brain fog extends to difficulties with word retrieval and performing calculations at work. Such severe executive functioning difficulties can result in one in five women quitting their jobs due to these symptoms. The fluctuations in estrogen and related neurotransmitters, such as serotonin, norepinephrine, and dopamine, are particularly disruptive, and Haver states that estrogen therapy may be more beneficial for women developing depression in perimenopause than SSRIs.
Haver explains that the fluctuations in hormone levels during perimenopause, which create a hormonal "zone of chaos," can considerably increase mental health disorders. These disturbances significantly impact neurotransmitters like serotonin and dopamine. Treatments that supply just enough estrogen to stabilize the hypothalamus without necessarily suppressing ovulation are critical for managing symptoms. Haver also mentions the correlation between hot flashes and psychological symptoms such as palpitations or an intense feeling of sadness.
During menopause, Haver elaborates on the transition leading to an increase in the percentage of visceral fat — from about 8% premenopausally to 23% postmenopausally — without changes in diet and exercise. Such changes influence the basal metabolic rate and insulin resistance, thereby affecting the risk of cardiometabolic disease. The consequent loss of muscle and gain of visceral fat are almost universally experienced, with visceral ...
Symptoms and effects of perimenopause and menopause
Andrew Huberman and Mary Claire Haver discuss ways to improve outcomes for those in perimenopause or menopause through lifestyle, diet, and resistance training.
Mary Claire Haver talks about the importance of an anti-inflammatory diet to manage menopausal symptoms, mentioning her own creation, the Galveston Diet, which incorporates aspects of the Mediterranean diet, fasting, and is tailored to be palatable for Americans.
Haver highlights the significance of protein in the diet, stating that women may need between 80 to 120 grams per day depending on their body composition. She references research suggesting that higher protein intake is associated with lower frailty scores in women. The recommended amount is around 1.5 to 1.7 grams per kilogram of lean body mass, which is higher than the general FDA recommendation of 0.8 grams. She also mentions the importance of spreading protein intake evenly throughout the day.
Regular exercise, particularly resistance training, is emphasized by Haver as crucial for improving outcomes during perimenopause and menopause. She shares her shift in focus from being thin to improving bone and muscle strength, and she actively engages in resistance training three to four times a week. Haver encourages the use of a personal trainer to develop ...
Lifestyle and nutritional approaches to managing perimenopause and menopause
Hormone replacement therapy (HRT), particularly estrogen therapy, has been highlighted as crucial for managing symptoms and reducing long-term health risks associated with menopause and perimenopause.
Mary Claire Haver emphasized the essential role of estrogen in managing menopause symptoms. HRT doses, which were initially developed to stop hot flashes, are crucial to normalization of serotonin levels and stabilization of the thermoregulatory center in the hypothalamus according to both Haver and Andrew Huberman. In treating premature ovarian insufficiency, aggressive hormone therapy was suggested, which is about three to four times the amount needed by a reproductive-aged woman. Moreover, it was brought to light that the technology has been beneficial for issues like dry eyes, vertigo, and has consistently provided protection for bones, the genital urinary system, and skin.
It was noted that women on HRT combined with GLP-1 medication experienced a 30% increased weight loss, highlighting the interplay between estrogen therapy and metabolic processes. Additionally, the utility of progestin, particularly when administered orally at night, has been recognized for its ability to settle the brain and promote sleep, likely due to its effects on GABA.
The timing of initiating HRT was stressed to be critical, especially when HRT starts between the ages of 50 to 59, which is associated with a 50% decreased risk of cardiovascular disease, death from cardiovascular disease, and all-cause mortality. The American Heart Association corroborated this by finding that starting HRT in this age range significantly reduces cardiovascular complications. Estrogen's preventive capabilities, particularly in the coronary arteries, were highlighted by Haver, who also mentioned the importance of its anti-inflammatory properties.
The conversation acknowledges that HRT is not suitable for all women. Women with a history of hormone-sensitive cancers, severe liver disease, or those currently experiencing blood clots should avoid HRT since estrogen is metabolized ...
Hormone replacement therapy (HRT) for perimenopause and menopause
Various treatments and lifestyle approaches are available to help manage menopausal symptoms, and while some have been studied extensively, evidence for others' efficacy remains mixed.
Mary Claire Haver suggests there may be benefits of specific supplements for menopausal individuals. She discusses a cream with estriol for facial application, which may slow down the loss of collagen during the first five years of menopause. While Haver does not directly mention oral collagen supplements, she highlights a bioactive collagen that showed improvements in bone density in menopausal women with osteoporosis. Additionally, she speaks positively about Verisol, a supplement that might reduce wrinkles and cellulite, and Fortibone, which could improve bone density.
Haver also mentions creatine, recommending creatine monohydrate, specifically five grams a day, for muscle preservation based on studies in women. She adds that vitamin D is recommended for patients who are deficient and struggle with absorption.
However, Haver expresses skepticism about a new supplement called Equal, indicating the absence of robust studies supporting its use, demonstrating that not all supplements are backed by substantial evidence.
The discussion reveals alternatives to traditional hormone therapies, such as testosterone therapy, which has off-label benefits for bone density and muscle strength. This suggests a potential adjunctive use in managing musculoskeletal aspects of menopausal symptoms.
Mary Claire Haver discusses the importance of lifestyle interventions in managing the symptoms of menopause. She emphasizes sleep hygiene, an important factor in symptom management. Haver notes that alcohol can impact the quality of sleep for menopausal women and advises reducing alcohol intake to avoid sleep disturbances.
She acknowledges that acupuncture may alleviate menopausal symptoms, althou ...
Other treatments and supplements for managing menopausal symptoms
Download the Shortform Chrome extension for your browser